Leftagraph

Every financial statement,
one clean chart.

Search any US-listed company. Data straight from SEC filings.

PROBuild your own list with the screener

AYTU BIOPHARMA, INC. (AYTU) financial statements

Number look wrong? Tell us

Data table
PROBuild your own list with the screener

AYTU BIOPHARMA, INC. (AYTU), most recent 12 months reported: revenue $57.57M, net loss $14.25M, free cash flow $3.25M. Latest balance sheet on file: liquid cash $26.31M, total debt $17.03M, net cash $9.28M. From SEC filings. Others in Pharmaceutical Preparations: AbCellera Biologics Inc. · WAVE LIFE SCIENCES, INC. · ENANTA PHARMACEUTICALS, INC · Bicycle Therapeutics plc · Nektar Therapeutics · PROTHENA CORPORATION PUBLIC LIMITED COMPANY · Aquestive Therapeutics, Inc. · Tango Therapeutics, Inc.

Stock screener

Watchlist